These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25005767)

  • 1. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.
    Young JS; Morshed RA; Kim JW; Balyasnikova IV; Ahmed AU; Lesniak MS
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1733-46. PubMed ID: 25005767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic cell carriers: a potential road to cure glioma.
    Young JS; Kim JW; Ahmed AU; Lesniak MS
    Expert Rev Neurother; 2014 Jun; 14(6):651-60. PubMed ID: 24852229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
    Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
    Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?
    Auffinger B; Morshed R; Tobias A; Cheng Y; Ahmed AU; Lesniak MS
    Oncotarget; 2013 Mar; 4(3):378-96. PubMed ID: 23594406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell Therapy of Gliomas.
    Parker Kerrigan BC; Hossain A; Yamashita S; Lang FF
    Prog Neurol Surg; 2018; 32():124-151. PubMed ID: 29990980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
    Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viruses, gene therapy and stem cells for the treatment of human glioma.
    Kyritsis AP; Sioka C; Rao JS
    Cancer Gene Ther; 2009 Oct; 16(10):741-52. PubMed ID: 19644531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy.
    Kim CK; Ahmed AU; Auffinger B; Ulasov IV; Tobias AL; Moon KS; Lesniak MS
    Mol Ther; 2013 Nov; 21(11):2063-73. PubMed ID: 23883863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
    Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
    Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.
    Morgan RA; Johnson LA; Davis JL; Zheng Z; Woolard KD; Reap EA; Feldman SA; Chinnasamy N; Kuan CT; Song H; Zhang W; Fine HA; Rosenberg SA
    Hum Gene Ther; 2012 Oct; 23(10):1043-53. PubMed ID: 22780919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.
    Jiang H; Gomez-Manzano C; Lang FF; Alemany R; Fueyo J
    Curr Gene Ther; 2009 Oct; 9(5):422-7. PubMed ID: 19860656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
    Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
    Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells as vehicles for the treatment of brain cancer.
    Mapara KY; Stevenson CB; Thompson RC; Ehtesham M
    Neurosurg Clin N Am; 2007 Jan; 18(1):71-80, ix. PubMed ID: 17244555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
    Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
    Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncolytic viruses in the therapy of gliomas].
    Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
    Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
    Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological horizons for targeting brain malignancy.
    Hughes SA; Achanta P; Ho AL; Duenas VJ; Quiñones-Hinojosa A
    Adv Exp Med Biol; 2010; 671():93-104. PubMed ID: 20455498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of neural stem cells in cancer gene therapy: predicting the path to the clinic.
    Ahmed AU; Alexiades NG; Lesniak MS
    Curr Opin Mol Ther; 2010 Oct; 12(5):546-52. PubMed ID: 20886386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma.
    Hai C; Jin YM; Jin WB; Han ZZ; Cui MN; Piao XZ; Shen XH; Zhang SN; Sun HH
    Chin J Cancer; 2012 May; 31(5):233-40. PubMed ID: 22429494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.